Reata Pharmaceuticals (NASDAQ:RETA) Price Target Raised to $173 00 at Robert W Baird themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA – Get Free Report) was downgraded by Guggenheim from a “buy” rating to a “neutral” rating in a note issued to investors on Friday, FlyOnTheWall reports. RETA has been the subject of several other reports. Stifel Nicolaus lowered Reata Pharmaceuticals from a “buy” rating to a “hold” rating in a report on […]
HighMark Wealth Management LLC grew its holdings in shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Free Report) by 119.7% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,269 shares of the company’s stock after purchasing an additional 11,588 shares during the quarter. Reata Pharmaceuticals […]
Reata Pharmaceuticals (NASDAQ:RETA – Free Report) had its target price boosted by Barclays from $98.00 to $110.00 in a report released on Wednesday, The Fly reports. A number of other equities research analysts have also issued reports on RETA. Robert W. Baird increased their target price on shares of Reata Pharmaceuticals from $40.00 to $85.00 […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Rating) shares gapped down before the market opened on Wednesday after Cantor Fitzgerald lowered their price target on the stock from $138.00 to $110.00. The stock had previously closed at $105.37, but opened at $89.50. Reata Pharmaceuticals shares last traded at $83.06, with a volume of 1,146,539 shares traded. […]